吉利电动车极氪9月交付 目标第四季销量八千辆
浙江吉利总裁安聪慧向《彭博电视台》表示,将利用新电动车极氪(ZEEKR)001来与苹果(AAPL.US)及小米(01810.HK)等有意进军电动汽车市场的公司竞争,目标将极氪发展成为全球品牌,目标到2022年底或2023年初进军欧洲及美国市场。
吉利已经花费4年时间来研发极氪,并将於9月开始交付,目标在第四季销售8,000辆。安聪慧表示,在增加两个车款後,目标到明年销售将上升至逾5万辆。
他又称,将仿傚蔚来(NIO.US)的做法,极氪建立自家生态系统,提供电动单车及智能手表等产品,同时还计划在2024年发布一款可以在自驾车使用的Zeekr机器人。
极氪在获得政府补贴後,售价由28.1万元人民币起,续航里程达710公里。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.